Modulation of human blood lymphocyte cytotoxicity by the phorbol ester tumor promoter P(Bu)2: Increase of target binding, impairment of effector recycling, and activation of lytic potential which is independent of IL-2
- 1 March 1985
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 91 (1) , 178-192
- https://doi.org/10.1016/0008-8749(85)90042-5
Abstract
No abstract availableThis publication has 63 references indexed in Scilit:
- Rapid kinetics of lysis in human natural cell-mediated cytotoxicity: Some implicationsCellular Immunology, 1983
- Phorbol 12,13-dibutyrate (P(Bu)2)-treated human blood mononuclear cells bind to each otherCellular Immunology, 1983
- Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes: requirement for reactive metabolites of oxygen.Journal of Clinical Investigation, 1982
- Interferon‐Induced NK Augmentation in HumansScandinavian Journal of Immunology, 1981
- Natural killing of tumor cells by human peripheral blood cells. Suppression of killing in vitro by tumor-promoting phorbol diesters.Journal of Clinical Investigation, 1981
- Phorbol myristic acetate enhances the production of Interleukin 2Cellular Immunology, 1981
- In vitro generation of K562 killers in human T-lymphocyte subsetsCellular Immunology, 1980
- Natural killer cells are responsible for the interferon production induced in human lymphocytes by tumor cell contactEuropean Journal of Immunology, 1980
- Suppression of natural antitumour defence mechanisms by phorbol estersNature, 1979
- Surface Markers on Human B and T LymphocytesScandinavian Journal of Immunology, 1976